 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 4231 | 回復(fù): 9 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||
zhuchunyue新蟲 (初入文壇)
|
[交流]
請問又碰到過小修之后還重新指定審稿人審稿的嗎？
|
||
|
投了一個微生物學(xué)雜志（Microbiology and Immunology）方面的文章，第一次結(jié)果是大修，返修當(dāng)天結(jié)果就是Awaiting reviewer scores，就是送給原審稿人審稿了； 今天早上，結(jié)果返回來了是小修，就是幾個語法、拼寫以及用詞問題，不涉及到文章內(nèi)容問題，結(jié)果狀態(tài)就變成Awaiting reviewer assignment。。。 這是又要重新指派審稿人的節(jié)奏嗎？？ 有點暈乎啊。。 難道是我這次看到小修都是語法錯誤，重修速度太快了，早上8點給我的修回意見，我中午12點就返修回去了。。。。。 他是下午兩點改的這種狀態(tài)。。 哎 大意失荊州啊。。 主要是人生第一篇論文，拙計了。。 （因為硬幣不多就10個了~ ） 下面是兩次返修的意見。。 Major Revision (28-Apr-2015)： Associate Editor Comments to Author: Associate Editor Comments to the Author: (There are no comments.) Reviewer(s)' Comments to Author: Reviewer: 1 Comments to the Author The manuscript by Zhu et al. evaluated attenuated Salmonella vaccine strain harboring htrA and yncD mutations. The manuscript is understandable but there are several critical points in the manuscript. (1) Authors should describe the reason why authors chose htrA and yncD double mutant strain for Salmonella enterica serovar Parathyphi A vaccine strain more. (2) Table 2 is the important result. Authors should show the result more adequately. Describe how many times the experiments were repeated and the mean ± SD. (3) How can LD50 be estimated by “l(fā)ogistic regression analysis” (page 6, lines 9, 10)? (4) Many grammatical and careless mistakes are found through the manuscript. I show some examples below. Page 2, line 9 and others. “the wild-type” is not accurate. “the wild-type strain” is better. Page 2, lines 10, 11. Add “a” before “human enteric fever vaccine” and “vaccine delivery vector”. Page 4, line 14. “Kanamycin” reads “kanamycin”. Page 7, line 4. Remove “assay” after “ELISA”. Page 8, line 3. “the yncD mutant and the wild-type did” should be “the yncD mutant strain and the wild-type strain”. Page 8, line 9. Add ”strains” before “(Fig. 2b)”. Page 8, line 16. Add “,” before “respectively”. Page 8, line 17. “the wild-type is” should be “the wild-type strain”. Page 9, line 1. “l(fā)iter” reads “titer”. Page 9, line 3. Remove “assay” after “ELISA”. Page 9, line 4. Remove “did” after “PBS control”. Page 9, line 9. “mucin mouse model” is strange expression. Just use “mouse model”. Page 10, line 5. The sentence, “the mutant strains either lose…reduced.” is grammatically wrong. Page 10, line 13. “and was attenuated” is grammatically wrong. Page 10, line 2 from the bottom. “Up to date” is strange. “should be to have” should be “should have”. Page 11, line 3. Add a space between “under” and “development”. References. Some references use the full journal name and others use the abbreviated form. Follow the author instruction. Figure legends. Page 16, line 2. “PCR Identification” reads “PCR identification”. Page 16, lines 7, 8. “mutant and the wild-type” should be “mutant strain and the wild-type strain”. Page 16, line 8. “mucin mouse model” should be “mouse model”. Page 16, line 3 from the bottom. “ELISA assay” should be “ELISA”. Table 2 (Page 18). In the title of Table 2, “wild-type” should be “wild-type strain” and “mucin mouse model” should be “mouse model”. Figure 2 (Page 20). The label of y-axis (Lg (CFU/ml)) should be changed. Explanation of “p<0.05” is necessary. Which groups were compared? Figure 3 (Page 21). It is not necessary to show bar graphs to show LD50. A table is better. Describe SD or SEM. Reviewer: 2 Comments to the Author The authors present evidence that double deletion of htrA and yncD on genome of Salmonella enterica serovar Paratyphi A resulted in remarkable decreased virulence compared with that of wild type using mucin mice model. They further show that the double deleted mutant is a candidate as an attenuate vaccine of S. Paratyphi A infection. This is an interesting work of S. Paratyphi A infection and vaccine. This reviewer has a few questions; 1. Usually, S. Pratyphi A could not infect mouse. The authors should explain about the mucin mice model which they assessed S. Paratyphi A virulence. How does S. Paratyphi A kill mice? Does S. Paratyphi A increase in any organs in mice? 2. It is interested that which gene (htrA or yncD) more contribute to the pathogenicity of S. Paratyphi A. The authors should examine the effect of each gene deletion on S. Paratyphi A virulence. --------------------------------------------------------我是華麗麗的分水嶺----------------------------------------------------------- Minor Revision (09-Jun-2015)： Associate Editor Comments to Author: Associate Editor Comments to the Author: (There are no comments.) Reviewer(s)' Comments to Author: Reviewer: 1 Comments to the Author The manuscript by Zhu et al. evaluated attenuated Salmonella vaccine strain harboring htrA and yncD mutations. The manuscript was significantly improved after revision. I just suggest several corrections. Page 1, line 20. “Lipopolysaccharide” reads “l(fā)ipopolysaccharide”. Page 8, line 164. Remove “Co. Ltd.” Add location of the company. Page 9, line 169. “Independent-samples T test” should be “Unpaired t test”. Page 9, line 185. “bacterial sensitivity” should be “bacterial vulnerability”. Page 10, line 191. “a 33.3% of mortality rate” should be “a mortality rate of 33.3%”. Page 11, line 229. “produced” should be “observed”. Page 12, line 244. “stressed” reads “stresses”. Page 13, line 267. “date” reads “data”. Page 13, line 269. Use “as…so far” instead of “by now”. Page 20, line 401. “Independent-samples T test” should be “Unpaired t test”. Page 21, line 420. “the wild-type strains” reads “the wild-type strain”. Page 22, Figure 1. Schemas of Figure 1a and Figure 1b are opposite. DK primers are for yncD gene and HK primers are for htrA gene. Page 27, Table 1. It is better to use capitals (A, G, C, T) instead of small letters (a, g, c, t) for the oligonucleotide sequences. Reviewer: 2 Comments to the Author Dear Authors, Thank you for the revised manuscript. It is shown clearly for my comments. 從小修來看 審稿人1 覺得很滿意 但是提了些小的語法問題 審稿人二 就是很水的寫了句同意他的意思。 按照這個意思，應(yīng)該會很快就給結(jié)果。。 結(jié)果 重新指定審稿人啷個意思偶。。 [ Last edited by zhuchunyue on 2015-6-10 at 19:17 ] |
回復(fù)此樓» 猜你喜歡
299求調(diào)劑
已經(jīng)有8人回復(fù)
-
一志愿北京理工大學(xué)本科211材料工程294求調(diào)劑
已經(jīng)有6人回復(fù)
-
300求調(diào)劑，材料科學(xué)英一數(shù)二
已經(jīng)有8人回復(fù)
-
招收生物學(xué)/細胞生物學(xué)調(diào)劑
已經(jīng)有5人回復(fù)
-
070305高分子化學(xué)與物理 304分求調(diào)劑
已經(jīng)有7人回復(fù)
-
289求調(diào)劑
已經(jīng)有13人回復(fù)
-
一志愿哈爾濱工業(yè)大學(xué)材料與化工方向336分
已經(jīng)有9人回復(fù)
-
081200-11408-276學(xué)碩求調(diào)劑
已經(jīng)有6人回復(fù)
-
調(diào)劑求院校招收
已經(jīng)有5人回復(fù)
-
調(diào)劑310
已經(jīng)有8人回復(fù)
» 本主題相關(guān)價值貼推薦，對您同樣有幫助:
- 投文章小修后審稿人意見和編輯意見不一致聽誰的？
已經(jīng)有13人回復(fù)
- 小修提交后，又under review了，是又送到原來審稿人手里了嗎？
已經(jīng)有10人回復(fù)
- 大修之后小修，小修之后被拒了，但是有重投機會，求問我該怎么辦？
已經(jīng)有8人回復(fù)
- 文章給了小修，請教大家該如何處理？
已經(jīng)有29人回復(fù)
- Optics Letters小修后還要返回審稿人嗎？
已經(jīng)有16人回復(fù)
- 文章回復(fù)小修，但是不太明白審稿人的這幾個問題，求高人解釋下，謝謝！
已經(jīng)有7人回復(fù)
- 小修后還要送回審稿人審，是邀請新的審稿人嗎？
已經(jīng)有19人回復(fù)
- 文章被拒，編輯建議重投后，還是原來的審稿人么
已經(jīng)有25人回復(fù)
- 一個拒稿，一個小修，再送審至哪個審稿人？
已經(jīng)有7人回復(fù)
- 論文已被編輯接收，但是有一個審稿人要求小修，我還需要回復(fù)他嗎?
已經(jīng)有4人回復(fù)
- 悲劇啊~ 小修后又重新送審
已經(jīng)有11人回復(fù)
- 大修終于回來了，要小修，有一個審稿人難纏咋辦呀
已經(jīng)有6人回復(fù)
- 為什么每修回一次，編輯都給我重新找新的審稿人？怎么回事？求解答
已經(jīng)有14人回復(fù)
- 大修過程中，自己除了審稿人給的意見外，發(fā)現(xiàn)一些小的語法錯誤
已經(jīng)有19人回復(fù)
- 小修，只有1個審稿人的意見，返回后又under review了，詭異的日期居然會改變？
已經(jīng)有17人回復(fù)
- 審稿意見全是小修，認真修回后卻被拒了。這是啥情況？
已經(jīng)有47人回復(fù)
- 大修返回快20天，發(fā)現(xiàn)狀態(tài)是又重新分配了審稿人，是不是要被拒了？忑忑，擔(dān)心ing
已經(jīng)有9人回復(fù)
- JHM二次小修 審稿人意見
已經(jīng)有11人回復(fù)
- 大修之后還會送原來的審稿人嗎？
已經(jīng)有12人回復(fù)
- 論文小修還用返給審稿人嗎
已經(jīng)有13人回復(fù)
- 小修沒有完全回答審稿人意見，會不會悲劇��？
已經(jīng)有21人回復(fù)
- 有一個審稿人意見明顯拒了,但編輯給的是小修,錄用機率有多少?
已經(jīng)有29人回復(fù)
- 編輯小修，三個審稿人有一個較為負面該怎么回答
已經(jīng)有7人回復(fù)
- 文章小修可否對審稿人的意見不加以答復(fù)？
已經(jīng)有10人回復(fù)
- 文章小修以后編輯會再發(fā)給審稿人嗎？
已經(jīng)有9人回復(fù)
- 投稿MSE-C請教各位蟲友，小修還會返回給審稿人嗎
已經(jīng)有17人回復(fù)
zhuchunyue
新蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 32.1
- 帖子: 20
- 在線: 3.7小時
- 蟲號: 1686937
- 注冊: 2012-03-13
- 專業(yè): 特種醫(yī)學(xué)(航空、航天、航海
9樓2015-06-10 20:53:53
zhuchunyue
新蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 32.1
- 帖子: 20
- 在線: 3.7小時
- 蟲號: 1686937
- 注冊: 2012-03-13
- 專業(yè): 特種醫(yī)學(xué)(航空、航天、航海
2樓2015-06-10 18:43:18
nono2009
超級版主 (文學(xué)泰斗)
No gains, no pains.
-
專家經(jīng)驗: +21105 - SEPI: 10
- 應(yīng)助: 28684 (院士)
- 貴賓: 513.911
- 金幣: 2555230
- 散金: 27828
- 紅花: 2148
- 沙發(fā): 66666
- 帖子: 1602255
- 在線: 65200.9小時
- 蟲號: 827383
- 注冊: 2009-08-13
- 性別: GG
- 專業(yè): 工程熱物理與能源利用
- 管轄: 科研家籌備委員會
4樓2015-06-10 19:09:48
zhuchunyue
新蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 32.1
- 帖子: 20
- 在線: 3.7小時
- 蟲號: 1686937
- 注冊: 2012-03-13
- 專業(yè): 特種醫(yī)學(xué)(航空、航天、航海
5樓2015-06-10 19:13:17
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿鄭州大學(xué)，080500學(xué)碩，總分317分求調(diào)劑 +5 | 舉個栗子oi 2026-03-24 | 6/300 |
|
|---|---|---|---|---|
|
[考研] 求調(diào)劑一志愿海大，0703化學(xué)學(xué)碩304分，有大創(chuàng)項目，四級已過 +7 | 幸運哩哩 2026-03-22 | 11/550 |
|
|
|
[考研] 一志愿華理，數(shù)一英一285求A區(qū)調(diào)劑 +8 | AZMK 2026-03-25 | 12/600 |
|
|
|
[考研] 275求調(diào)劑 +10 | Micky11223 2026-03-25 | 14/700 |
|
|
|
[考研] 求調(diào)劑 +3 | QiMing7 2026-03-25 | 4/200 |
|
|
|
[考研]
 材料與化工考研調(diào)劑
+17
|
孅華 2026-03-22 | 17/850 |
|
|
|
[考博] 26申博 +3 | 加油沖�。� 2026-03-26 | 3/150 |
|
|
|
[考研] 調(diào)劑 +3 | 李嘉圖·S·路 2026-03-27 | 3/150 |
|
|
|
[考研] 材料求調(diào)劑 +5 | .m.. 2026-03-25 | 5/250 |
|
|
|
[考研] 327求調(diào)劑 +7 | prayer13 2026-03-23 | 7/350 |
|
|
|
[考研] 調(diào)劑 +4 | 柚柚yoyo 2026-03-26 | 4/200 |
|
|
|
[考研] 081200-11408-276學(xué)碩求調(diào)劑 +3 | 崔wj 2026-03-26 | 3/150 |
|
|
|
[考研] 求調(diào)劑 +8 | Auroracx 2026-03-22 | 8/400 |
|
|
|
[考研] 340求調(diào)劑 +3 | Amber00 2026-03-26 | 3/150 |
|
|
|
[考研] 一志愿天津大學(xué)339材料與化工求調(diào)劑 +3 | 江往賣魚 2026-03-26 | 3/150 |
|
|
|
[考研] 一志愿上海交大生物與醫(yī)藥專碩324分，求調(diào)劑 +6 | jiajunX 2026-03-22 | 6/300 |
|
|
|
[考研] 334分 一志愿武理-080500 材料求調(diào)劑 +4 | 李李不服輸 2026-03-25 | 4/200 |
|
|
|
[考研] 材料專碩 335 分求調(diào)劑 +4 | 拒絕冷暴力 2026-03-25 | 4/200 |
|
|
|
[考研] 【2026考研調(diào)劑】制藥工程 284分 求相關(guān)專業(yè)調(diào)劑名額 +4 | 袁奐奐 2026-03-25 | 8/400 |
|
|
|
[考研] 285求調(diào)劑 +3 | AZMK 2026-03-24 | 3/150 |
|